Sprouty4 interferes with cell proliferation and migration of breast cancer-derived cell lines
- PMID: 24402575
- DOI: 10.1007/s13277-013-1587-0
Sprouty4 interferes with cell proliferation and migration of breast cancer-derived cell lines
Abstract
Sprouty proteins are modulators of mitogen-induced signal transduction processes and therefore can influence the process of cancerogenesis. In particular, Sprouty2 has been shown to have an important role in cancer development of many tumor entities including breast cancer. In this report, we investigated the role of Sprouty4 in breast cancer-derived cell lines. We have found that ectopic Sprouty4 expression inhibits cell proliferation of breast cancer cell lines independently of their endogenous expression levels. Corroborating Sprouty4 downregulation causes accelerated growth. Furthermore, we demonstrate that an increase in Sprouty4 content interferes with serum-induced activation of mitogen-activated protein kinase pathway. Additionally, Sprouty4 expression negatively influences cell migration. These data suggest that Sprouty4 is a possible candidate for a tumor suppressor in breast cancer.
Similar articles
-
Sprouty3 and Sprouty4, Two Members of a Family Known to Inhibit FGF-Mediated Signaling, Exert Opposing Roles on Proliferation and Migration of Glioblastoma-Derived Cells.Cells. 2019 Aug 1;8(8):808. doi: 10.3390/cells8080808. Cells. 2019. PMID: 31374860 Free PMC article.
-
Sprouty4 negatively regulates protein kinase C activation by inhibiting phosphatidylinositol 4,5-biphosphate hydrolysis.Oncogene. 2009 Feb 26;28(8):1076-88. doi: 10.1038/onc.2008.464. Epub 2009 Jan 12. Oncogene. 2009. PMID: 19137008
-
Sprouty2 but not Sprouty4 is a potent inhibitor of cell proliferation and migration of osteosarcoma cells.FEBS Lett. 2013 Aug 19;587(16):2597-605. doi: 10.1016/j.febslet.2013.06.040. Epub 2013 Jul 4. FEBS Lett. 2013. PMID: 23831057
-
The Golgi in cell migration: regulation by signal transduction and its implications for cancer cell metastasis.ScientificWorldJournal. 2012;2012:498278. doi: 10.1100/2012/498278. Epub 2012 May 1. ScientificWorldJournal. 2012. PMID: 22623902 Free PMC article. Review.
-
Sprouty proteins, masterminds of receptor tyrosine kinase signaling.Angiogenesis. 2008;11(1):53-62. doi: 10.1007/s10456-008-9089-1. Epub 2008 Jan 25. Angiogenesis. 2008. PMID: 18219583 Review.
Cited by
-
MicroRNA‑181 serves an oncogenic role in breast cancer via the inhibition of SPRY4.Mol Med Rep. 2018 Dec;18(6):5603-5613. doi: 10.3892/mmr.2018.9572. Epub 2018 Oct 22. Mol Med Rep. 2018. Retraction in: Mol Med Rep. 2022 May;25(5):157. doi: 10.3892/mmr.2022.12673. PMID: 30365052 Free PMC article. Retracted.
-
H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma.Nucleic Acids Res. 2017 Apr 7;45(6):3086-3101. doi: 10.1093/nar/gkw1247. Nucleic Acids Res. 2017. PMID: 27956498 Free PMC article.
-
MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells.PLoS One. 2016 Aug 11;11(8):e0161023. doi: 10.1371/journal.pone.0161023. eCollection 2016. PLoS One. 2016. PMID: 27513462 Free PMC article.
-
Oncogenic microRNA-411 promotes lung carcinogenesis by directly targeting suppressor genes SPRY4 and TXNIP.Oncogene. 2019 Mar;38(11):1892-1904. doi: 10.1038/s41388-018-0534-3. Epub 2018 Nov 2. Oncogene. 2019. PMID: 30390072 Free PMC article.
-
A Sprouty4 Mutation Identified in Kallmann Syndrome Increases the Inhibitory Potency of the Protein towards FGF and Connected Processes.Int J Mol Sci. 2021 Feb 21;22(4):2145. doi: 10.3390/ijms22042145. Int J Mol Sci. 2021. PMID: 33670044 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous